Selective Lymphadenectomy for Salvage Esophagectomy in Patients with Esophageal Squamous Cell Carcinoma

被引:9
|
作者
Mayanagi, Shuhei [1 ]
Haneda, Ryoma [1 ,2 ]
Inoue, Masazumi [1 ]
Ishii, Kenjiro [1 ]
Tsubosa, Yasuhiro [1 ]
机构
[1] Shizuoka Canc Ctr Hosp, Div Esophageal Surg, Shizuoka, Japan
[2] Hamamatsu Univ Sch Med, Dept Surg, Hamamatsu, Shizuoka, Japan
关键词
DEFINITIVE CHEMORADIOTHERAPY; CANCER; METAANALYSIS; STRATEGY; SURGERY;
D O I
10.1245/s10434-022-11625-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Extensive lymph node dissection increases the risk of postoperative complications, especially in salvage surgery, after definitive chemoradiotherapy (>= 50 Gy) in patients with esophageal squamous cell carcinoma. The purpose of this retrospective study is to compare the outcomes of salvage esophagectomy with selective lymphadenectomy of only clinically positive lymph nodes. Methods Clinically positive lymph nodes, diagnosed as metastases using computed and positron emission tomography performed before chemoradiotherapy or salvage surgery, were targeted for dissection in selective lymphadenectomy. We compared postoperative complications between 52 patients who underwent salvage esophagectomy with selective lymphadenectomy and 207 controls who underwent nonsalvage esophagectomy with 3-field lymphadenectomy. We also analyzed postoperative recurrence pattern and survival in salvage group. Results The mean number of dissected lymph nodes was 12.9 in the salvage esophagectomy group compared with 48.1 in the 3-field lymphadenectomy group (p < 0.001). Differences in the number of postoperative complications, comparing Clavien-Dindo all-grade and >= grade 3, were not significant between the groups. Both 30- and 90-day mortality were 0% (0/52) in the salvage group. Five cases had recurrence only in the locoregional area without distant metastasis. Of these five cases, only one had recurrence in the subcarinal lymph node without prophylactic mediastinal lymphadenectomy. A 3-year recurrence-free survival and 3-year overall survival from salvage esophagectomy were 43.3% and 46.3%, respectively. Conclusions It may contribute to obtaining good short- and long-term outcomes by dissecting only clinically positive lymph nodes in salvage esophagectomy.
引用
收藏
页码:4863 / 4870
页数:8
相关论文
共 50 条
  • [41] Multimodality Treatment and Prognosis in Esophageal Squamous Cell Carcinoma Requiring Esophagectomy
    Yamashita, Keishi
    Katada, Natsuya
    Moriya, Hiromitsu
    Hosoda, Kei
    Sakuramoto, Shinichi
    Kikuchi, Shiroh
    Watanabe, Masahiko
    [J]. HEPATO-GASTROENTEROLOGY, 2014, 61 (132) : 1042 - 1048
  • [42] Open vs. thoracoscopic Esophagectomy for Esophageal Squamous cell carcinoma
    Brink, F.
    Jaehne, J.
    [J]. CHIRURG, 2014, 85 (06): : 542 - 542
  • [43] Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience
    Mitchell, K. G.
    Nelson, D. B.
    Corsini, E. M.
    Vaporciyan, A. A.
    Antonoff, M. B.
    Mehran, R. J.
    Rice, D. C.
    Roth, J. A.
    Sepesi, B.
    Walsh, G. L.
    Bhutani, M. S.
    Maru, D. M.
    Wu, C. C.
    Nguyen, Q-N
    Ajani, J. A.
    Swisher, S. G.
    Hofstetter, W. L.
    [J]. DISEASES OF THE ESOPHAGUS, 2020, 33 (03)
  • [44] Prognostic Value of Body Mass Index for Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma
    Cheng, Yufeng
    Wang, Nana
    Wang, Kai
    Wang, Jianbo
    Tan, Bingxu
    Jia, Yibin
    Dou, Yan
    Yu, Jinming
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (02) : 146 - 153
  • [45] Predictive factors for early recurrence in patients with esophageal squamous cell carcinoma after curative esophagectomy
    Shimizu, Hiroki
    Shiozaki, Atsushi
    Fujiwara, Hitoshi
    Komatsu, Shuhei
    Ichikawa, Daisuke
    Okamoto, Kazuma
    Murayama, Yasutoshi
    Kuriu, Yoshiaki
    Ikoma, Hisashi
    Nakanishi, Masayoshi
    Ochiai, Toshiya
    Kokuba, Yukihito
    Otsuji, Eigo
    [J]. ESOPHAGUS, 2012, 9 (01) : 17 - 24
  • [46] Prognostic value of an immunohistochemical signature in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy
    Meng, Jin
    Zhang, Junhua
    Xiu, Yingjie
    Jin, Yan
    Xiang, Jiaqing
    Nie, Yongzhan
    Fu, Shen
    Zhao, Kuaile
    [J]. MOLECULAR ONCOLOGY, 2018, 12 (02) : 196 - 207
  • [47] Adjuvant chemotherapy in node-positive patients after esophagectomy for esophageal squamous cell carcinoma
    Jeon, Yeong Jeong
    Cho, Jong Ho
    Choi, Yong Soo
    Shim, Young Mog
    Sun, Jong-Mu
    Kim, Hong Kwan
    [J]. THORACIC CANCER, 2023, 14 (06) : 624 - 635
  • [48] Prognostic Significance of Glasgow prognostic score in patients undergoing esophagectomy for esophageal squamous cell carcinoma
    Feng, Ji-Feng
    Zhao, Qiang
    Chen, Qi-Xun
    [J]. SAUDI JOURNAL OF GASTROENTEROLOGY, 2014, 20 (01): : 48 - 53
  • [49] Right Compared With Left Thoracic Approach Esophagectomy for Patients With Middle Esophageal Squamous Cell Carcinoma
    Zheng, Yan
    Li, Yin
    Liu, Xianben
    Zhang, Ruixiang
    Sun, Haibo
    Xing, Wenqun
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [50] Comprehensive Analysis of Multiple Primary Cancers in Patients With Esophageal Squamous Cell Carcinoma Undergoing Esophagectomy
    Yoshida, Naoya
    Eto, Kojiro
    Kurashige, Junji
    Izumi, Daisuke
    Sawayama, Hiroshi
    Horinouchi, Tomo
    Iwatsuki, Masaaki
    Baba, Yoshifumi
    Miyamoto, Yuji
    Baba, Hideo
    [J]. ANNALS OF SURGERY, 2022, 276 (02) : 305 - 311